Trinity Biotech Announces World Health Organisation Approval Of TrinScreen HIV
Trinity Biotech plc (NASDAQ:TRIB) has received approval for its new HIV screening product, TrinScreen™ HIV, from the World Health Organisation (WHO).
TrinScreen™ HIV
Trinity Biotech's